• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Adverse effects of fluoroquinolones.

作者信息

Shimada J, Hori S

机构信息

Division of Clinical Pharmacology, St. Marianna University School of Medicine, Kawasaki, Japan.

出版信息

Prog Drug Res. 1992;38:133-43.

PMID:1609111
Abstract

The newer fluoroquinolones have various kinds of adverse reactions and drug-drug interactions. Patients given concurrent therapy of fluoroquinolones with theophylline should be carefully observed. It is better to avoid concurrent therapy of fluoroquinolones with NSAIDs, and patients given fluoroquinolones who have a history of central nervous system disorders should be put under careful observation, because of the possibility of central nervous system reactions. Fluoroquinolones should be carefully administered to patients with compromised renal functions, because fluoroquinolones are accumulated in patients with impaired renal function. Although fluoroquinolones have various kinds of adverse reactions, the frequency of toxicity is considered to be acceptable. However careful, clinical and experimental studies should be continued to reveal more details on the adverse reactions of fluoroquinolones.

摘要

相似文献

1
Adverse effects of fluoroquinolones.
Prog Drug Res. 1992;38:133-43.
2
Adverse reactions and interactions of fluoroquinolones.
Clin Invest Med. 1989 Feb;12(1):28-34.
3
The safety profile of the fluoroquinolones.氟喹诺酮类药物的安全性概况。
Clin Ther. 2000 Jul;22(7):798-817; discussion 797. doi: 10.1016/S0149-2918(00)80053-3.
4
A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.一种新型呼吸喹诺酮类药物——口服吉米沙星:综合安全性概况
Int J Antimicrob Agents. 2004 May;23(5):421-9. doi: 10.1016/j.ijantimicag.2004.02.014.
5
Risks associated with the therapeutic use of fluoroquinolones.氟喹诺酮类药物治疗相关风险。
Expert Opin Drug Saf. 2013 Jul;12(4):497-505. doi: 10.1517/14740338.2013.796362. Epub 2013 May 7.
6
Microbiologic aspects of fluoroquinolones.氟喹诺酮类药物的微生物学特性
Am J Ophthalmol. 1991 Oct;112(4 Suppl):15S-24S.
7
[Quinolones and their central nervous system toxicities].[喹诺酮类药物及其中枢神经系统毒性]
Ryoikibetsu Shokogun Shirizu. 1999(27 Pt 2):552-7.
8
Fluoroquinolone toxicity profiles: a review focusing on newer agents.氟喹诺酮类药物的毒性概况:聚焦新型药物的综述
Clin Infect Dis. 1999 Feb;28(2):352-64. doi: 10.1086/515104.
9
Toxicity of quinolones.喹诺酮类药物的毒性
Drugs. 1999;58 Suppl 2:37-42. doi: 10.2165/00003495-199958002-00007.
10
Antimicrobial safety and tolerability: differences and dilemmas.抗菌药物的安全性与耐受性:差异与困境
Clin Infect Dis. 2001 Mar 15;32 Suppl 1:S72-9. doi: 10.1086/319379.

引用本文的文献

1
Depressive and Other Adverse CNS Effects of Fluoroquinolones.氟喹诺酮类药物的抑郁及其他中枢神经系统不良反应
Pharmaceuticals (Basel). 2023 Aug 4;16(8):1105. doi: 10.3390/ph16081105.
2
Quinolones: review of psychiatric and neurological adverse reactions.喹诺酮类药物:精神和神经系统不良反应综述。
Drug Saf. 2011 Jun 1;34(6):465-88. doi: 10.2165/11587280-000000000-00000.
3
Defluorinated sparfloxacin as a new photoproduct identified by liquid chromatography coupled with UV detection and tandem mass spectrometry.经液相色谱结合紫外检测及串联质谱鉴定的新型光产物——去氟司帕沙星
Antimicrob Agents Chemother. 1998 May;42(5):1151-9. doi: 10.1128/AAC.42.5.1151.